Ossianix
Oxford, United Kingdom· Est. 2012
Ossianix develops biological drugs from shark single domain antibodies. We specialize in blood-brain barrier penetrant biologics.
Private Company
Total funding raised: $11.8M
About
Ossianix develops biological drugs from shark single domain antibodies. We specialize in blood-brain barrier penetrant biologics.
AntibodiesBiologics
Funding History
2Total raised:$11.8M
Series A$10MNov 15, 2021
Seed$1.8MApr 15, 2019